Publications by authors named "Pia Schilling"

Background: Antibiotic-containing carrier systems are one option that offers the advantage of releasing active ingredients over a longer period of time. In vitro sustained drug release from a carrier system consisting of microporous β-TCP ceramic and alginate has been reported in previous works. Alginate dialdehyde (ADA) gelatin gel showed both better mechanical properties when loaded into a β-TCP ceramic and higher biodegradability than pure alginate.

View Article and Find Full Text PDF
Article Synopsis
  • * The alginate-di-aldehyde-gelatin gel was used in a specialized loading chamber to fill the microporous ceramics, and the release of clindamycin and BMP-2 was monitored using advanced techniques like HPLC and ELISA at various time points.
  • * Findings indicated a significant initial release of clindamycin with high efficacy, while BMP-2 was released in lower concentrations, suggesting the need to investigate the biocompatibility and potential of this alginate-gelatin gel
View Article and Find Full Text PDF

The aim of the present work was to develop a dual staged drug release of an antibiotic (clindamycin) and a growth factor: bone morphogenetic protein-2 (BMP-2) from a biodegradable system consisting of hydrogel and gelatin nanoparticles (GNP). Two-step de-solvation allowed us to prepare GNPs (~100 nm) as drug carriers. Fluorescein isothiocyanate (FITC)-conjugated protein A was used as a model substance for BMP-2.

View Article and Find Full Text PDF

The aim of this work was to establish an organ model for staphylococcal infection of human bone samples and to investigate the influence and efficacy of a microporous β-tricalcium phosphate ceramic (β-TCP, RMS Foundation) loaded with hydrogels (alginate, alginate-di-aldehyde (ADA)-gelatin) and clindamycin on infected human bone tissue over a period of 28 days. For this purpose, human tibia plateaus, collected during total knee replacement surgery, were used as a source of bone material. Samples were infected with S.

View Article and Find Full Text PDF

In the present work, an ex vivo organ model using human bone (explant) was developed for the evaluation of the initial osseointegration behavior of implant materials. The model was tested with additive manufactured Ti6Al4V test substrates with different 3D geometries. Explants were obtained from patients who underwent total knee replacement surgery.

View Article and Find Full Text PDF

The objective of this study was to vary the wall thicknesses and pore sizes of inversely printed 3D molded bodies. Wall thicknesses were varied from 1500 to 2000 to 2500 µm. The pores had sizes of 500, 750 and 1000 µm.

View Article and Find Full Text PDF

This work aimed to determine the influence of two hydrogels (alginate, alginate-di-aldehyde (ADA)/gelatin) on the mechanical strength of microporous ceramics, which have been loaded with these hydrogels. For this purpose, the compressive strength was determined using a Zwick Z005 universal testing machine. In addition, the degradation behavior according to ISO EN 10993-14 in TRIS buffer pH 5.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Pia Schilling"

  • - Pia Schilling's recent research focuses on the development of advanced biomaterials for enhanced drug delivery systems, particularly aimed at treating bone infections and facilitating osseointegration through the use of biodegradable composites and hydrogels.
  • - Her studies demonstrate the effectiveness of composite materials, such as β-TCP ceramics combined with alginate-dialdehyde-gelatin, for the controlled dual release of antibiotics and growth factors over extended periods, showcasing promising results in both in vitro and ex vivo models.
  • - Schilling's work includes innovative methodologies, like a human bone infection organ model and ex vivo assessments for implant materials, contributing to the understanding of material interactions with biological tissues and improving treatment strategies for bone-related ailments.